KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $39.6 million.

  • Staar Surgical's Other Accumulated Expenses rose 182.22% to $39.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year increase of 182.22%. This contributed to the annual value of $43.1 million for FY2024, which is 524.94% up from last year.
  • Latest data reveals that Staar Surgical reported Other Accumulated Expenses of $39.6 million as of Q3 2025, which was up 182.22% from $37.1 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Other Accumulated Expenses registered a high of $47.7 million during Q1 2025, and its lowest value of $19.4 million during Q2 2022.
  • For the 5-year period, Staar Surgical's Other Accumulated Expenses averaged around $32.4 million, with its median value being $31.9 million (2021).
  • As far as peak fluctuations go, Staar Surgical's Other Accumulated Expenses skyrocketed by 7318.31% in 2021, and later crashed by 356.37% in 2022.
  • Staar Surgical's Other Accumulated Expenses (Quarter) stood at $31.9 million in 2021, then fell by 3.56% to $30.7 million in 2022, then surged by 33.17% to $40.9 million in 2023, then increased by 5.25% to $43.1 million in 2024, then fell by 8.05% to $39.6 million in 2025.
  • Its Other Accumulated Expenses stands at $39.6 million for Q3 2025, versus $37.1 million for Q2 2025 and $47.7 million for Q1 2025.